Abstract
Recent dramatic progress in molecular biology is being translated into improved or new vaccines to prevent infectious diseases. The ability to clone genetic material, to manipulate it to express high quality, purified antigens and to make recombinant vectors is leading to a new generation of safe and effective vaccines. The introduction of these new vaccines will be an ongoing process involving multiple manufacturers of vaccines from many countries. The purpose of this chapter is to summarize the types of vaccines and technologies that are likely to emerge as significant advances in vaccinology as we approach the twenty-first century.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ACP Task Force on Adult Immunization and Infectious Diseases Society of America (1994) Guide for adult Immunization, 3rd edn. American College of Physicians, 1994
Stein KE (1994) Glycoconjugate vaccines. The promise of new technologies. Int J Technol Assess Health Care 10(1): 167–176
Anderson EL, Decker MD, Englund JA, Edwards KM, Anderson P, Mclnnes P, Belshe RB (1995) Interchangeability of conjugated Haemophilus influenzae type b vaccines in Infants. JAMA 273:849–853
Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly, J, Mendelman PM (1996) Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 128:649–653
Belshe RB, Karron RA, Newman FK, Anderson EL, Nugent SL, Steinhoff M, Clements ML, Wilson MH, Hall SL, Tierney EL, Murphy BR (1992) Evaluation of a live attenuated, cold-adapted parainfluenzae virus type 3 vaccine in children. J Clin Microbiol 30:2064–2070
Belshe RB, Swierkosz, EM, Anderson EL, Newman FK, Nugent SL, Maassab J (1992) Immunization of infants and young children with live attenuated trivalent cold recombinant influenza A H1N1, H3N2, and B vaccine. J Infect Dis 165:727–732
La Montagne JR, Rabinovich NR (1994) The promise of new technologies. Int J Technol Assess Health Care 10(1): 7–13
Mekalanos JJ (1994) Live attenuated vaccine vectors. The promise of new technologies. Int J Technol Assess Health Care 10(1): 131–142
Gray BM, Converse GM, Dillon HC (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis 142:923–933
Ellis RW, Douglas RG Jr (1994) Combination vaccines. The promise of new technologies. Int J Technol Assess Health Care 10(1): 185–192
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Belshe, R.B. (1998). Vaccines for the Twenty-First Century. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology VII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80466-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-80466-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63360-0
Online ISBN: 978-3-642-80466-3
eBook Packages: Springer Book Archive